Acute ethanol inhibits dopamine release in the nucleus accumbens via α6 nicotinic acetylcholine receptors

Nathan Schilaty, David M. Hedges, Eun Young Jang, Ryan J. Folsom, Jordan T. Yorgason, J. Michael McIntosh, Scott C. Steffensen

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Electrophysiology and microdialysis studies have provided compelling evidence that moderate to high ethanol concentrations enhance dopamine (DA) neurotransmission in the nucleus accumbens (NAc) through the mesolimbic DA system. However, with fast-scan cyclic voltammetry, short-term exposure to moderate to high doses of ethanol decreases evoked DA release at terminals in the NAc. The aim of this study was to evaluate the involvement of nicotinic acetylcholine receptors (nAChRs) in modulating the effects of ethanol on DA release in the NAc of C57BL/6 mice ex vivo and in vivo. Local stimulation evoked robust, frequency-dependent DA release in the NAc slice preparation, with maximal release at 40 Hz in the shell and 20 Hz in the core. Nicotine decreased DA release in a concentration-dependent (0.01-10 μM) manner in the shell and core, with an IC50 of 0.1 μM ex vivo and 0.5 mg/kg in vivo. Nicotine and ethanol inhibition of DA release was blocked by the α6 *-nAChR antagonist α-conotoxins CtxMII and a-CtxMII [H9A; L15A] ex vivo (100 nM) in the core but not the shell. Furthermore, the nonspecific nAChR antagonist mecamylamine (2 mg/kg) blocked the effects of ethanol in the core in vivo. These findings suggest that DA release is inhibited by ethanol via nAChRs in the NAc and that DA modulation by nAChRs differs in the core versus the shell, with α6*-nAChRs affecting DA release in the core but not in the shell.

Original languageEnglish (US)
Pages (from-to)559-567
Number of pages9
JournalJournal of Pharmacology and Experimental Therapeutics
Volume349
Issue number3
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Nucleus Accumbens
Nicotinic Receptors
Dopamine
Ethanol
Nicotine
Conotoxins
Mecamylamine
Electrophysiology
Microdialysis
Inbred C57BL Mouse
Synaptic Transmission
Inhibitory Concentration 50

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Acute ethanol inhibits dopamine release in the nucleus accumbens via α6 nicotinic acetylcholine receptors. / Schilaty, Nathan; Hedges, David M.; Jang, Eun Young; Folsom, Ryan J.; Yorgason, Jordan T.; McIntosh, J. Michael; Steffensen, Scott C.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 349, No. 3, 01.01.2014, p. 559-567.

Research output: Contribution to journalArticle

Schilaty, Nathan ; Hedges, David M. ; Jang, Eun Young ; Folsom, Ryan J. ; Yorgason, Jordan T. ; McIntosh, J. Michael ; Steffensen, Scott C. / Acute ethanol inhibits dopamine release in the nucleus accumbens via α6 nicotinic acetylcholine receptors. In: Journal of Pharmacology and Experimental Therapeutics. 2014 ; Vol. 349, No. 3. pp. 559-567.
@article{d4210f31e02140139e3f997bfcdf99ad,
title = "Acute ethanol inhibits dopamine release in the nucleus accumbens via α6 nicotinic acetylcholine receptors",
abstract = "Electrophysiology and microdialysis studies have provided compelling evidence that moderate to high ethanol concentrations enhance dopamine (DA) neurotransmission in the nucleus accumbens (NAc) through the mesolimbic DA system. However, with fast-scan cyclic voltammetry, short-term exposure to moderate to high doses of ethanol decreases evoked DA release at terminals in the NAc. The aim of this study was to evaluate the involvement of nicotinic acetylcholine receptors (nAChRs) in modulating the effects of ethanol on DA release in the NAc of C57BL/6 mice ex vivo and in vivo. Local stimulation evoked robust, frequency-dependent DA release in the NAc slice preparation, with maximal release at 40 Hz in the shell and 20 Hz in the core. Nicotine decreased DA release in a concentration-dependent (0.01-10 μM) manner in the shell and core, with an IC50 of 0.1 μM ex vivo and 0.5 mg/kg in vivo. Nicotine and ethanol inhibition of DA release was blocked by the α6 *-nAChR antagonist α-conotoxins CtxMII and a-CtxMII [H9A; L15A] ex vivo (100 nM) in the core but not the shell. Furthermore, the nonspecific nAChR antagonist mecamylamine (2 mg/kg) blocked the effects of ethanol in the core in vivo. These findings suggest that DA release is inhibited by ethanol via nAChRs in the NAc and that DA modulation by nAChRs differs in the core versus the shell, with α6*-nAChRs affecting DA release in the core but not in the shell.",
author = "Nathan Schilaty and Hedges, {David M.} and Jang, {Eun Young} and Folsom, {Ryan J.} and Yorgason, {Jordan T.} and McIntosh, {J. Michael} and Steffensen, {Scott C.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1124/jpet.113.211490",
language = "English (US)",
volume = "349",
pages = "559--567",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Acute ethanol inhibits dopamine release in the nucleus accumbens via α6 nicotinic acetylcholine receptors

AU - Schilaty, Nathan

AU - Hedges, David M.

AU - Jang, Eun Young

AU - Folsom, Ryan J.

AU - Yorgason, Jordan T.

AU - McIntosh, J. Michael

AU - Steffensen, Scott C.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Electrophysiology and microdialysis studies have provided compelling evidence that moderate to high ethanol concentrations enhance dopamine (DA) neurotransmission in the nucleus accumbens (NAc) through the mesolimbic DA system. However, with fast-scan cyclic voltammetry, short-term exposure to moderate to high doses of ethanol decreases evoked DA release at terminals in the NAc. The aim of this study was to evaluate the involvement of nicotinic acetylcholine receptors (nAChRs) in modulating the effects of ethanol on DA release in the NAc of C57BL/6 mice ex vivo and in vivo. Local stimulation evoked robust, frequency-dependent DA release in the NAc slice preparation, with maximal release at 40 Hz in the shell and 20 Hz in the core. Nicotine decreased DA release in a concentration-dependent (0.01-10 μM) manner in the shell and core, with an IC50 of 0.1 μM ex vivo and 0.5 mg/kg in vivo. Nicotine and ethanol inhibition of DA release was blocked by the α6 *-nAChR antagonist α-conotoxins CtxMII and a-CtxMII [H9A; L15A] ex vivo (100 nM) in the core but not the shell. Furthermore, the nonspecific nAChR antagonist mecamylamine (2 mg/kg) blocked the effects of ethanol in the core in vivo. These findings suggest that DA release is inhibited by ethanol via nAChRs in the NAc and that DA modulation by nAChRs differs in the core versus the shell, with α6*-nAChRs affecting DA release in the core but not in the shell.

AB - Electrophysiology and microdialysis studies have provided compelling evidence that moderate to high ethanol concentrations enhance dopamine (DA) neurotransmission in the nucleus accumbens (NAc) through the mesolimbic DA system. However, with fast-scan cyclic voltammetry, short-term exposure to moderate to high doses of ethanol decreases evoked DA release at terminals in the NAc. The aim of this study was to evaluate the involvement of nicotinic acetylcholine receptors (nAChRs) in modulating the effects of ethanol on DA release in the NAc of C57BL/6 mice ex vivo and in vivo. Local stimulation evoked robust, frequency-dependent DA release in the NAc slice preparation, with maximal release at 40 Hz in the shell and 20 Hz in the core. Nicotine decreased DA release in a concentration-dependent (0.01-10 μM) manner in the shell and core, with an IC50 of 0.1 μM ex vivo and 0.5 mg/kg in vivo. Nicotine and ethanol inhibition of DA release was blocked by the α6 *-nAChR antagonist α-conotoxins CtxMII and a-CtxMII [H9A; L15A] ex vivo (100 nM) in the core but not the shell. Furthermore, the nonspecific nAChR antagonist mecamylamine (2 mg/kg) blocked the effects of ethanol in the core in vivo. These findings suggest that DA release is inhibited by ethanol via nAChRs in the NAc and that DA modulation by nAChRs differs in the core versus the shell, with α6*-nAChRs affecting DA release in the core but not in the shell.

UR - http://www.scopus.com/inward/record.url?scp=84901189140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901189140&partnerID=8YFLogxK

U2 - 10.1124/jpet.113.211490

DO - 10.1124/jpet.113.211490

M3 - Article

VL - 349

SP - 559

EP - 567

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -